DI TRANA, ANNAGIULIA

DI TRANA, ANNAGIULIA  

Dipartimento Scienze Biomediche e Sanita' Pubblica  

Mostra records
Risultati 1 - 15 di 15 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autore(i) File
3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining 1-gen-2022 Carlier, J.; Berardinelli, D.; Montanari, E.; Sirignano, A.; Di Trana, A.; Busardo, F. P.
A comprehensive HPLC–MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid 1-gen-2020 Di Trana, A.; Mannocchi, G.; Pirani, F.; La Maida, N.; Gottardi, M.; Pichini, S.; Busardo, F. P.
A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020 1-gen-2021 La Maida, N.; Di Trana, A.; Giorgetti, R.; Tagliabracci, A.; Busardo, F. P.; Huestis, M. A.
Adulterants in drugs of abuse: a recent focus of a changing phenomenon 1-gen-2022 Di Trana, A.; Montanari, E.
Biomedical analysis of New Psychoactive Substances (NPS) of natural origin 1-gen-2019 Lo Faro, A. F.; Di Trana, A.; La Maida, N.; Tagliabracci, A.; Giorgetti, R.; Busardo, F. P.
Commentary: Tele-COVID-19: Does it improve the provision of health services? 1-gen-2021 Di Trana, A.; Busardo, F. P.; Ricci, G.; Sirignano, A.
Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances 1-gen-2020 Di Trana, A.; Carlier, J.; Berretta, P.; Zaami, S.; Ricci, G.
Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases 1-gen-2020 Mannocchi, G.; Di Trana, A.; Tini, A.; Zaami, S.; Gottardi, M.; Pichini, S.; Busardo, F. P.
Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 1-gen-2020 Perez-Acevedo, A. P.; Busardo, F. P.; Pacifici, R.; Mannocchi, G.; Gottardi, M.; Poyatos, L.; Papaseit, E.; Perez-Mana, C.; Martin, S.; Di Trana, A.; Pichini, S.; Farre, M.
In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites 1-gen-2021 Di Trana, A.; Brunetti, P.; Giorgetti, R.; Marinelli, E.; Zaami, S.; Busardo, F. P.; Carlier, J.
Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance 1-gen-2019 Busardo, F. P.; Di Trana, A.; Montanari, E.; Mauloni, S.; Tagliabracci, A.; Giorgetti, R.
Monitoring Prenatal Exposure to Buprenorphine and Methadone 1-gen-2020 Di Trana, A.; La Maida, N.; Tittarelli, R.; Huestis, M. A.; Pichini, S.; Busardo, F. P.; Carlier, J.
Profiling of in vitro metabolism of New Psychoactive Substances 15-giu-2022 DI TRANA, Annagiulia
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 1-gen-2020 Carlier, J.; La Maida, N.; Di Trana, A.; Huestis, M. A.; Pichini, S.; Busardo, F. P.
β'-Phenylfentanyl Metabolism in Primary Human Hepatocyte Incubations: Identification of Potential Biomarkers of Exposure in Clinical and Forensic Toxicology 1-gen-2023 Brunetti, Pietro; Lo Faro, Alfredo F; Di Trana, Annagiulia; Montana, Angelo; Basile, Giuseppe; Carlier, Jeremy; Busardò, Francesco P